Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Chronic Rhinosinusitis Without Nasal Polyps
Clinical Trial
NCT06013241Last updated: 12/4/2025
INSM
Insmed Incorporated
